BIM
AGN

Bridges Investment Management’s Allergan Inc AGN Stock Holding History

Bridges Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,200
Closed -$255K – 143
2014
Q4 		$255K Hold
1,200
– – 0.05% 127
2014
Q3 		$214K Sell
1,200
-3,409
-74% -$566K 0.04% 134
2014
Q2 		$780K Buy
4,609
+950
+26% +$148K 0.15% 90
2014
Q1 		$454K Sell
3,659
-10,000
-73% -$1.22M 0.09% 103
2013
Q4 		$1.52M Hold
13,659
– – 0.34% 61
2013
Q3 		$1.24M Buy
13,659
+1,000
+8% +$89.8K 0.31% 64
2013
Q2 		$1.07M Buy
+12,659
New +$1.31M 0.28% 67

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Bridges Investment Management's AGN Position: Q1 2015 in Review

Bridges Investment Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,200 shares — an estimated $255K sold.

Bridges Investment Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.52M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Bridges Investment Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Bridges Investment Management sold 1,200 Allergan Inc shares in Q1 2015, an estimated $255K.
  • Bridges Investment Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Bridges Investment Management's Allergan Inc position peaked at $1.52M in Q4 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Bridges Investment Management's 13F filing for Q1 2015, filed 24 Apr 2015.